Spanakis, E.K. and S.H. Golden, Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep, 2013. 13(6): p. 814-23.
Rodriguez, J.E. and K.M. Campbell, Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes. Clin Diabetes, 2017. 35(1): p. 66-70.
Cheng, Y.J., et al., Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016. JAMA, 2019. 322(24): p. 2389-2398.
Karter, A.J., et al., Ethnic disparities in diabetic complications in an insured population. JAMA, 2002. 287(19): p. 2519-27.
An, J., et al., Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care, 2021. 9(1).
Wong, T.Y., et al., Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol, 2006. 141(3): p. 446-455.
Holman, R.R., et al., 10-year follow-up of intensive glucose control in type 2 diabetes. The New England journal of medicine, 2008. 359(15): p. 1577-89.
Laiteerapong, N., et al., The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care, 2019. 42(3): p. 416-426.
Lind, M., et al., Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88. Diabetes Care, 2021.
Nichols, G.A., C. Conner, and J.B. Brown, Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice. Curr Med Res Opin, 2010. 26(9): p. 2127-35.
American Diabetes Association Professional Practice, C., et al., 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. Diabetes Care, 2022. 45(Suppl 1): p. S125-S143.
Elhussein, A., et al., Racial/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study. Lancet Reg Health Am, 2022. 6.
Goonesekera, S.D., et al., Racial ethnic differences in type 2 diabetes treatment patterns and glycaemic control in the Boston Area Community Health Survey. BMJ Open, 2015. 5(5): p. e007375.
Trinacty, C.M., et al., Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res, 2009. 9: p. 24.
Mathur, R., et al., Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study. PLoS Med, 2020. 17(5): p. e1003106.
Karter, A.J., et al., Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE). Diabetes Care, 2013. 36(3): p. 574-9.
Parker, M.M., et al., An algorithm to identify medication nonpersistence using electronic pharmacy databases. J Am Med Inform Assoc, 2015. 22(5): p. 957-61.
Delate, T., G. Albrecht, and K.L. Olson, Out-of-plan pharmacy use by members of a managed care organization. Perm J, 2012. 16(2): p. 15-21.
Karter, A.J., et al., Glycemic response to newly initiated diabetes therapies. Am J Manag Care, 2007. 13(11): p. 598-606.
Zou, G., A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol, 2004. 159(7): p. 702-6.
Wang, M.C., et al., Age at Diagnosis of Diabetes by Race and Ethnicity in the United States From 2011 to 2018. JAMA Intern Med, 2021. 181(11): p. 1537-1539.
Balasubramanian, B.A., et al., Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore), 2017. 96(11): p. e6326.
Gopalan, A., et al., Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes. Diabetes Care, 2020.
American Diabetes Association Professional Practice, C., et al., 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care, 2022. 45(Suppl 1): p. S83-S96.
Marcondes, F.O., et al., Are racial/ethnic minorities recently diagnosed with diabetes less likely than white individuals to receive guideline-directed diabetes preventive care? BMC Health Serv Res, 2021. 21(1): p. 1150.
Lopez, J.M., et al., Characterization of type 2 diabetes mellitus burden by age and ethnic groups based on a nationwide survey. Clin Ther, 2014. 36(4): p. 494-506.
Golden, S.H., The contribution of structural racism to metabolic health disparities in the USA. Lancet Diabetes Endocrinol, 2021. 9(8): p. 478-480.
Egede, J.K., et al., Perceived Stress as a Pathway for the Relationship Between Neighborhood Factors and Glycemic Control in Adults With Diabetes. Am J Health Promot, 2022. 36(2): p. 269-278.
Assari, S., et al., Racial Discrimination in Health Care Is Associated with Worse Glycemic Control among Black Men but Not Black Women with Type 2 Diabetes. Front Public Health, 2017. 5: p. 235.
Charlson, M.E., et al., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 1987. 40(5): p. 373-83.
Messer, L.C., et al., The development of a standardized neighborhood deprivation index. J Urban Health, 2006. 83(6): p. 1041-62.
Brown, J.B., C. Conner, and G.A. Nichols, Secondary Failure of Metformin Monotherapy in Clinical Practice. Diabetes Care, 2010. 33(3): p. 501.
Centers for Disease Control and Prevention. Hispanic/Latino Americans and Type 2 Diabetes. 2019 30, 2020]; Available from: https://www.cdc.gov/diabetes/library/features/hispanic-diabetes.html.
Kanaya, A.M., et al., Heterogeneity of diabetes outcomes among asians and pacific islanders in the US: the diabetes study of northern california (DISTANCE). Diabetes Care, 2011. 34(4): p. 930-7.
Li, L., et al., Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2 diabetes. Journal of diabetes and its complications, 2015. 29(1): p. 32-7.
Hillier, T.A. and K.L. Pedula, Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes care, 2003. 26(11): p. 2999-3005.
Huo, X., et al., Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. The lancet. Diabetes & endocrinology, 2016. 4(2): p. 115-24.
Song, S.H. and T.A. Gray, Early-onset type 2 diabetes: high risk for premature diabetic retinopathy. Diabetes research and clinical practice, 2011. 94(2): p. 207-11.
McQuaid, E.L. and W. Landier, Cultural Issues in Medication Adherence: Disparities and Directions. Journal of general internal medicine, 2018. 33(2): p. 200-206.
Hall, W.J., et al., Implicit Racial/Ethnic Bias Among Health Care Professionals and Its Influence on Health Care Outcomes: A Systematic Review. Am J Public Health, 2015. 105(12): p. e60-76.
Green, A.R., et al., Implicit bias among physicians and its prediction of thrombolysis decisions for black and white patients. J Gen Intern Med, 2007. 22(9): p. 1231-8.
van Ryn, M. and J. Burke, The effect of patient race and socio-economic status on physicians’ perceptions of patients. Social Science & Medicine, 2000. 50(6): p. 813-828.
Fernandez, A., et al., Adherence to Newly Prescribed Diabetes Medications Among Insured Latino and White Patients With Diabetes. JAMA Intern Med, 2017. 177(3): p. 371-379.
Heisler, M., et al., Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med, 2007. 167(17): p. 1853-60.